{"id":3975,"date":"2023-10-02T12:43:33","date_gmt":"2023-10-02T09:43:33","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=3975"},"modified":"2026-10-30T13:29:45","modified_gmt":"2026-10-30T11:29:45","slug":"iasis-pharma-participation-in-the-developments-in-dermatology-venereology-2023","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/iasis-pharma-participation-in-the-developments-in-dermatology-venereology-2023\/","title":{"rendered":"IASIS PHARMA participation in the \u201cDevelopments in Dermatology &#038; Venereology 2023\u201d"},"content":{"rendered":"<p><strong>22 \u2013 24\/09\/2023<\/strong><\/p>\n<p><strong>Hermes Hotel, ERMOUPOLIS<\/strong>,<strong> SYROS ISLAND<\/strong><\/p>\n<p><strong>IASIS PHARMA<\/strong> participated in the <strong>&#8220;Developments in Dermatology &amp; Venereology 2023&#8221;<\/strong> conference which held on <strong>September 22-24 2023<\/strong>, at the <strong>Hermes Hotel<\/strong> in <strong>Syros Island<\/strong>.<\/p>\n<p>The conference was organized by the <strong>Hellenic College of Dermatology-Venereology<\/strong> with the scientific support of the <strong>2nd Clinic of Venereology and Skin Diseases of U.O.A<\/strong>.<\/p>\n<p>Dermatologists from all over Greece who attended the Conference had the chance to visit\u00a0<strong>IASIS PHARMA<\/strong>\u00a0exhibition stand and informed of IASIS major Dermatological products:<\/p>\n<ul>\n<li><strong>Isotroin<sup>\u00ae<\/sup><\/strong>\/Isotretinoin (in the <strong>new &amp; unique<\/strong> <strong>30mg<\/strong> dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy.<\/li>\n<li><strong>Combi<sup>\u00ae<\/sup><\/strong>, a combination of fluprednidene+miconazole cream for the treatment of Inflammatory Dermatomycoses.<\/li>\n<li><strong>Modiwart<sup>\u00ae<\/sup><\/strong>\/\u0399miquimod, an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.<\/li>\n<\/ul>\n<p>During the conference, <strong>IASIS PHARMA<\/strong> organized a <strong>Satellite Lecture<\/strong>, entitled:<\/p>\n<p><strong>The Value of Isotretinoin<\/strong>: &#8220;Advances in the Systemic Treatment of Acne&#8221;<\/p>\n<p><strong>&#8211;\u00a0 Chair: Dr N. Stavrianeas<\/strong>, Emeritus Professor of Dermatology of the University of Athens.<\/p>\n<p><strong>&#8211;\u00a0 Speaker: Dr A. Katoulis<\/strong>, Professor of Dermatology-Venereology School of Medicine, <strong>U.O.A<\/strong>., Professor and Chairman 2nd Dept. of Dermatology and Venereology Attikon University Hospital.<\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignleft wp-image-3967\" src=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/syros-1-copy-e1696238757849.png\" alt=\"syros-1-copy\" width=\"630\" height=\"575\" srcset=\"https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/syros-1-copy-e1696238757849-500x456.png 500w, https:\/\/iasispharma.com\/wp-content\/uploads\/2023\/10\/syros-1-copy-e1696238757849.png 700w\" sizes=\"(max-width: 630px) 100vw, 630px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>22 \u2013 24\/09\/2023 Hermes Hotel, ERMOUPOLIS, SYROS ISLAND IASIS PHARMA participated in the &#8220;Developments in Dermatology &amp; Venereology 2023&#8221; conference which held on September 22-24 2023, at the Hermes Hotel in Syros Island. The conference was organized by the Hellenic College of Dermatology-Venereology with the scientific support of the 2nd Clinic of Venereology and Skin  [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":true,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,145,157,204],"tags":[],"class_list":["post-3975","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-company-news","category-press-room-en","category-conferences"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-127","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=3975"}],"version-history":[{"count":2,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3975\/revisions"}],"predecessor-version":[{"id":3977,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/3975\/revisions\/3977"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=3975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=3975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=3975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}